ArticleEcology and evolution2023
Phylogenetic and biogeographic history of brook lampreys (
Article in Ecology and evolution, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A miniature, subterranean, blind cobitid loach, Gitchak nakana, new genus and species, is the first groundwater-dwelling fish from Northeast India.Scientific reports · 2026Article
- Phylogenomic resolution of lampreys reveals the recent evolution of an ancient vertebrate lineage.Proceedings. Biological sciences · 2025Article
- Species diversity in the new lamprey genus Occidentis, formerly classified as western North American 'Lampetra'.PloS one · 2024Article
- Phylogenetic and biogeographic history of brook lampreys (Ecology and evolution · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Adriatic brook lamprey,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.